Response to: `Correspondence on `Factors Associated with COVID-19-related Death in People with Rheumatic Diseases: Results from the COVID-19 Global Rheumatology Alliance Physician Reported Registry' by Arnaud and Devilliers
Pedro M Machado
(1)
,
Martin Schäfer
(2)
,
Anja Strangfeld
(2)
,
Laure Gossec
(3, 4)
,
Milena Gianfrancesco
(5)
,
Saskia Lawson-Tovey
(6, 7)
,
Elsa F Mateus
,
Loreto Carmona
(8)
,
Kimme L Hyrich
(6)
,
Philip C Robinson
,
Jinoos Yazdany
(5)
1
UCLH -
University College London Hospitals
2 DRFZ - Deutsches Rheuma-ForschungsZentrum
3 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
4 CHU Pitié-Salpêtrière [AP-HP]
5 UC - University of California
6 MAHSC - Manchester Academic Health Science Centre
7 Centre for Genetics and Genomics Versus Arthritis
8 InMusc - Instituto de Salud Musculoesqueletica
2 DRFZ - Deutsches Rheuma-ForschungsZentrum
3 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
4 CHU Pitié-Salpêtrière [AP-HP]
5 UC - University of California
6 MAHSC - Manchester Academic Health Science Centre
7 Centre for Genetics and Genomics Versus Arthritis
8 InMusc - Instituto de Salud Musculoesqueletica